血栓
血小板
血小板活化
医学
纳米技术
生物医学工程
材料科学
免疫学
外科
作者
Ting Yang,Xingwei Ding,Lei Dong,Can Hong,Jing Ye,Xiao Yan,Xiaolei Wang,Hong-Bo Xin
出处
期刊:ACS Biomaterials Science & Engineering
[American Chemical Society]
日期:2018-11-12
卷期号:4 (12): 4219-4224
被引量:24
标识
DOI:10.1021/acsbiomaterials.8b00979
摘要
Systemic thrombolytic drug administration has always gained an unideal therapeutic effect due to the rapid neutralization by its antidotes. It is significant to seek an approach for targeted thrombolytic drug delivery to the thrombus. Here a biocompatible, thrombus-targeted, and low-cost platelet-mimic nanovector was fabricated to accomplish a sustained urokinase plasminogen activator (uPA) release at the thrombus site. The prepared system presented a sustained model drug release behavior for 30 h and burst release behavior under near-infrared laser irradiation with hyperthermia in vitro. We demonstrate that the fabricated nanovectors can arrive and aggregate at the pulmonary thrombus, followed by a sustained uPA release in the murine pulmonary embolism model. Therefore, according to the results, the formulated nanovector presented a hopeful application for targeted thrombolytic therapy clinically.
科研通智能强力驱动
Strongly Powered by AbleSci AI